Sign In
Get Clay Free →

Suggestions

    Roger Pomerantz

    Director Board Of Directors at Viracta Therapeutics, Inc.

    Roger Pomerantz is a distinguished figure in the pharmaceutical industry, known for spearheading the development of 12 approved small and large molecule drugs across various disease areas like HIV, HCV, TB, CMV, and C Diff.

    Throughout his career, Roger has demonstrated exceptional leadership in completing over 160 business development, licensing, acquisition, and partnership deals in diverse therapeutic areas for both large and small molecules.

    Roger Pomerantz has an extensive academic background, with notable roles at Harvard Medical School, Massachusetts Institute of Technology, and The Johns Hopkins University, focusing on virology, infectious diseases, and molecular biology.

    In addition to his academic pursuits, Roger has held key positions in numerous pharmaceutical companies and biotechs, contributing his expertise in drug discovery, development, and infectious diseases.

    Roger Pomerantz's exemplary contributions extend to his involvement in various organizations and advisory roles, including serving as the Chair of the Board of Directors at Viracta Therapeutics, Inc., and holding leadership positions in multiple pharmaceutical companies and biotechs.

    Roger Pomerantz
    Add to my network

    Location

    Greater New York City Area